Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis

Tomasz Siwek; Katarzyna Jezierska-Woźniak; Stanisław Maksymowicz; Monika Barczewska; Mariusz Sowa; Wanda Badowska; Wojciech Maksymowicz

doi:10.12659/MSM.927484

10 December 2020 : Clinical Research

Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis

Tomasz Siwek^12ABDEFG*, Katarzyna Jezierska-Woźniak^3ABDEF, Stanisław Maksymowicz^4BCDEF, Monika Barczewska^56BD, Mariusz Sowa^57B, Wanda Badowska^8B, Wojciech Maksymowicz^57ADG

DOI: 10.12659/MSM.927484

Med Sci Monit 2020; 26:e927484

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 The monthly change in the total Revised Amyotrophic Lateral Sclerosis Functional Rating Scale scores before and during treatment, and the linear trend function for the treatment period based on data from the pretreatment observation period. The rate of progression increased. (Arrows indicate injections.)

Back to the Article

Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis

Your Privacy